Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Government Contract opportunity from Department Of Health And Human Services was posted on July 31, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Laboratory Solvent Evaporation Systems Supply

Closed
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 334510
New
Federal
Intent to Award Sole/Single Source - USAFSAM/ETB Ultrasound Task Trainer
Solicitation # IASS-AFRL-RMZB-2026-0051
The Air Force Research Laboratory Enterprise Strategies and Initiatives Contracting Division intends to award a sole source, firm fixed-price purchase order to Elevate Healthcare for an ultrasound task trainer to be used at the CSTARS Baltimore Sim Center (ETB) in Baltimore, Maryland. This procurement, identified by solicitation number IASS-AFRL-RMZB-2026-0051 under NAICS code 334510, aims to replace an outdated CPU-style simulator to modernize Point of Care Ultrasound (POCUS) training for Comprehensive Medical Readiness Program rotators, who utilize the facility for approximately 250 hours annually. Elevate Healthcare has been identified as the only vendor capable of providing a system that meets the physical requirements and fully integrates with established POCUS training protocols, ensuring continuity of instruction. The required hardware package must include a manikin, a laptop with installed software, an electromagnetic tracking system, a foot pedal, and necessary peripherals. Additionally, the vendor must provide cardiac and abdominal training packs, as well as curvilinear and TTE ultrasound replacement transducers. The contract requires a minimum one-year warranty and at least one day of virtual training. While the government is proceeding with a single source award under RFO 12.102(a), authorized distributors or responsible sources were given until September 15, 2026, to submit capability statements or exceptions to the sole source intent.
FA2396 USAF Afmc Afrl Pzl Afrl Pzle

POSTED

about 17 hours ago

DEADLINE

in 3 days

AI Contract Overview

Show more

The contract involves the supply of two TurboVap LV solvent evaporation systems along with necessary accessories for use in veterinary drug residue analysis at the FDA’s Denver laboratory. These systems are critical for efficiently removing solvents from samples during routine testing, ensuring accurate detection and quantification of residual veterinary pharmaceuticals in animal-derived products. The equipment is intended to support regulatory compliance and public health safety through enhanced laboratory capabilities. The solicitation is classified as a subcontract under NAICS code 334510, which corresponds to laboratory equipment manufacturing, and is managed by the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services. Performance of the contract will be based at the FDA facility in Denver, with no specific city or state indicated for the place of performance beyond the facility identifier 18888. The opportunity was posted on July 31, 2026, with proposals due by August 10, 2026. No set-aside designation or point of contact information is provided, and no additional details regarding technical specifications or delivery timelines are included in the posted data.

General Info

Supply of two TurboVap LV systems for veterinary drug residue analysis at FDA Denver lab.

Agency

Department Of Health And Human Services → FDA Office Of Acq Grant SvcsView Agency

NAICS

334510 - Electromedical and Electrotherapeutic Apparatus ManufacturingView NAICS

Place of Performance

18888, CO, USA

Set-Aside

NONE

Documents

This scope was carved out of FDA-HFP-2026-134777.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

TURBOVAP LV EVAPORATION SYSTEM (2EA)

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed
Posted

subcontract

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → FDA Office Of Acq Grant Svcs
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Health And Human Services → FDA Office Of Acq Grant Svcs
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Supply of two TurboVap LV solvent evaporation systems with accessories for veterinary drug residue analysis at FDA's Denver laboratory.

More opportunities from Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

Same awarding agency

NAICS: 541714
New
Federal
Human Hindbrain Organoid Functional Assay Services.
Solicitation # RFQ_CDR-2026-135968
The U.S. Food and Drug Administration, through the Center for Drug Evaluation and Research, intends to award a sole-source, firm-fixed-price purchase order to OrganoTherapeutics SARL for human iPSC-derived hindbrain organoid functional assay services. This acquisition, conducted under FAR Part 12 as a commercial service, aims to support in vitro research on drug-induced effects on respiratory-relevant neural circuits. The scope of work includes the provision of human hindbrain organoids and associated culture materials, with twelve scheduled deliveries to the FDA White Oak Campus in Silver Spring, Maryland. The first delivery will consist of 96 organoids, followed by eleven subsequent deliveries of 48 organoids each. The contractor will perform functional characterization at its own laboratory using three-dimensional multi-electrode array technology to assess electrophysiological responses to FDA-identified drug and reversal-agent combinations. Key deliverables include the raw and analyzed data, analysis files, and comprehensive study reports. The anticipated period of performance is 18 months from the date of award. Award will be based on best value, with technical capability and past performance weighted more heavily than price. All invoicing must be processed electronically through the U.S. Department of Treasury's Invoice Processing Platform.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

about 17 hours ago

DEADLINE

in 5 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS